Sean Maduck, President, Corcept Endocrinology, on September 01, 2026, sold 25,000 shares in Corcept Therapeutics (CORT) for $2,860,737. Following the Form 4 filing with the SEC, Maduck has control over a total of 119,655 common shares of the company, with 9,938 shares held directly and 109,717 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000119312526382474/xslF345X05/ownership.xml
Frederick R Wilson, Director, on September 01, 2026, sold 10,000 shares in Coinbase Global (COIN) for $1,789,295. Following the Form 4 filing with the SEC, Wilson has control over a total of 187,389 Class A common shares of the company, with 184,973 shares held directly and 2,416 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1679788/000167978826000106/xslF345X05/wk-form4_1788471072.xml
Patricia Gallup, 10% Owner, Director, Chairman & Chief Administrative Officer, on September 01, 2026, sold 14,284 shares in PC Connection (CNXN) for $1,139,439. Following the Form 4 filing with the SEC, Gallup has control over a total of 13,672,771 common shares of the company, with 533,758 shares held directly and 13,139,013 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1050377/000193004426000005/xslF345X05/primarydocument.xml
Vikas Bhalla, President of EXL, on September 01, 2026, sold 10,000 shares in Exlservice Holdings (EXLS) for $381,700. Following the Form 4 filing with the SEC, Bhalla has control over a total of 120,295 common shares of the company, with 120,295 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1297989/000162828026060385/xslF345X05/wk-form4_1788465697.xml